Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Marketwired

18:14 EST 20th November 2017 | BioPortfolio

Here are the most relevant search results for "Marketwired" found in our extensive news archives from over 250 global news sources.

More Information about Marketwired on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Marketwired for you to read. Along with our medical data and news we also list Marketwired Clinical Trials, which are updated daily. BioPortfolio also has a large database of Marketwired Companies for you to search.

Showing News Articles 1–25 of 12,000+ from Marketwired

Sunday 19th November 2017

SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update

SUWANEE, GA -- (Marketwired) -- 11/20/17 -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2017 on November 14 2017 and will provide a business update on a conference call at 10:00AM Eastern Time on Tuesday, November 21, 2017. Highlights of the third quarter and recent weeks: "We are very excited about the progress we are making ...

Rennova Health Reports Third Quarter 2017 Financial Results

WEST PALM BEACH, FL --(Marketwired - November 20, 2017) - Rennova Health, Inc. (OTCQB: RNVA) (OTCQB: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that opened its first rural hospital in Oneida, Tennessee on August 8, 2017, reports financial results for the three and nine months ended September 30, 2017 and provid...

Deciphering the Complexity of the Acute Leukemia Immunological Microenvironment with 3D Biology(TM) Technology, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - November 20, 2017) - Join the live session on Tuesday, December 5, 2017 at 12pm EST to learn more about how the combined analysis of SNV, mRNA, and protein expression on the nCounter system enabled a comprehensive characterization of the molecular landscape of leukemia cells. Guest speakers include Doug Hinerfeld, Ph.D., Principal Product Application Scientist at NanoSt...

New Brunswick becomes first province in Canada to fully secure safe supply of cannabis for all its consumers

ATHOLVILLE, NEW BRUNSWICK -- (Marketwired) -- 11/20/17 -- Note to Editors: A photo for this release will be available on the Canadian Press picture wire via Marketwired. In the largest deal of its kind, the government of New Brunswick today announced a Memorandum of Understanding (MOU) with Zenabis for the safe and secure supply of cannabis and cannabis derivatives for the province's recreationa...

Milestone Scientific Announces Planned Launch of Instrument for Botox Delivery

LIVINGSTON, NJ--(Marketwired - November 20, 2017) - Milestone Scientific Inc . (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that deliver painless and precise injections, today announced plans for the commercial launch of its novel and proprietary cosmetic injection instrument for delivery of botulinum toxin (such as Botox® and Dysport®). ...

Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner

LAVAL, QUEBEC -- (Marketwired) -- 11/20/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that the company recently entered into a non-binding term sheet with a leading...

Advanced Proteome Therapeutics Expands Antibody-Drug Conjugate Collaboration

VANCOUVER, BC--(Marketwired - November 20, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, is expanding the collaboration with the National Research Council of Canada (NRC) and receiving support from its Industrial Research Assistance Program (NRC IR...

Trillium Therapeutics' TTI-2341 EGFR Inhibitor Program Featured at the Society for Neuro-Oncology 22nd Annual Meeting

TORONTO, ONTARIO -- (Marketwired) -- 11/20/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that new preclinical data for its novel covalent EGFR inhibitor were presented at the Society for Neuro-Oncology 22nd Annual Meeting, November 16-19, in San Francisco. Poster Pr...

Improving Regulatory and Operational Performance in Orphan Drug Development, a New Webinar Presented by Premier Research and Hosted by Xtalks

TORONTO, ON--(Marketwired - November 20, 2017) - Today more than ever, regulatory bodies are providing a progressive platform for rare disease drug development. Extensions to existing regulations and incentives and attempts to reduce orphan drug designation applications provide a collaborative environment for companies developing orphan drugs. Understanding the regulatory landscape in orphan drug...

Thursday 16th November 2017

CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. - TSX-V: HIP) to Create a Premier Global Cannabis Company

SASKATOON, SASKATCHEWAN and OAKVILLE, ONTARIO -- (Marketwired) -- 11/17/17 -- Editors Note: A photo for this release is available on the Canadian Press picture wire via Marketwired. Transaction Highlights CanniMed Therapeutics Inc. (TSX: CMED) ("CanniMed") and Newstrike Resources Ltd. (TSX VENTURE: HIP) ("Newstrike") are pleased to announce that they have reached a definitive agreement (the "Ar...

Cerecor Acquires TRx Pharmaceuticals

BALTIMORE, MD--(Marketwired - November 17, 2017) - Cerecor Inc. (NASDAQ: CERC) and TRx Pharmaceuticals, LLC (TRx) today announced that the companies have entered into a purchase agreement in which Cerecor will acquire TRx, including subsidiary Zylera Pharmaceuticals, LLC and its franchise of commercial medications led by Poly-Vi-Flor® (multivitamin and fluoride supplement tablet, chewable) and T...

Cerecor Announces Leadership Changes

BALTIMORE, MD--(Marketwired - November 17, 2017) - Cerecor, Inc. (NASDAQ: CERC), a biopharmaceutical company focused on developing and commercializing innovative therapies that make a difference in the lives of patients, today announced key leadership changes, following the Company's recent acquisition of TRx Pharmaceuticals. TRx co-founders Randal O. Jones and Robert C. Moscato Jr. have been app...

Wednesday 15th November 2017

Hydropothecary Signals Support for Quebec's Bill 157

GATINEAU, QC--(Marketwired - November 16, 2017) - The Hydropothecary Corporation ("Hydropothecary") (TSX VENTURE: THCX) signals its support for Québec's Bill 157, governing the sale and distribution of adult use recreational cannabis. "With the introduction of Bill 157, governing the sale and distribution of cannabis for the adult recreational market, Quebec has taken its most significant step t...

Cosmos Holdings, Inc. Announces $3 Million Securities Purchase Agreement With Two Institutional Investors

CHICAGO, IL -- (Marketwired) -- 11/16/17 -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors. "We are excited to announce the addition of two institutional investors," said Grigorios Siokas, President and CEO of Cosmos Holdings. "This agreeme...

Aequus Granted European Patent for Once-Weekly Transdermal Aripiprazole

VANCOUVER, BC--(Marketwired - November 16, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that the European Patent Office has issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal pa...

SANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound Care

SUWANEE, GA -- (Marketwired) -- 11/16/17 -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned Clinical and Science Symposium on Advanced Wound Care to be held on December 8 and 9, 2017, in Atlanta, GA. This event will gather SANUWAVE's clinical researchers, science advisors, Key Opinion Leaders, and world-wide distributors to discuss extracorporeal shockwave technology as ...

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

OTTAWA, ONTARIO -- (Marketwired) -- 11/16/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. ("Aphria") under Access to Canna...

Titan Medical Reports First Use of Sport Surgical System at Columbia University Medical Center

TORONTO, ON--(Marketwired - November 16, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery ("MIS"), announces the completion at Columbia University Medical Center's surgical simulation center in New York City of ...

Angle PLC: Total Voting Rights and Covington Subscription

GUILDFORD, SURREY -- (Marketwired) -- 11/16/17 -- Angle PLC (OTCQX: ANPCY) (AIM: AGL) ANGLE plc ("the Company") Total Voting Rights and Covington Subscription ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, further to the announcement of 5 October 2017, 4,579,169 new ordinary shares of 10 pence each in the Company ("Ordinary Shares") were admitted to...

Tuesday 14th November 2017

CORRECTION - Results of New Clinical Study Show Epidural Space Correctly Identified in 100% of Labor & Delivery Patients Using Milestone Scientific's CompuFlo(TM) Epidural Instrument

LIVINGSTON, NJ--(Marketwired - November 15, 2017) - The company issued the following correction to reflect differences in translation and location. Milestone Scientific Inc. (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Dr. Camila Gonzalez of Department of Anesthesiology Davila Clinic, Los Andes U...

Titan Medical Announces Pricing of Marketed Offering of Units

TORONTO, ON--(Marketwired - November 15, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF) is pleased to announce today that it has priced its previously announced marketed offering (the "Offering") of units of the Company (the "Units") for minimum gross proceeds of CDN...

Trillium Announces Private Placement

TORONTO, ONTARIO -- (Marketwired) -- 11/15/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has entered into subscription agreements for the sale of 1,950,000 common shares and 400,000 Series II non-voting convertible first preferred shares at a price of U.S.$8...

GeoVax HIV Clinical Trials Update

ATLANTA, GA -- (Marketwired) -- 11/15/17 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced that the HIV Vaccine Trials Network (HVTN) has closed enrollment for the phase 1 human clinical trial evaluating late boosts of GeoVax's preventive vaccine (GOVX-B11) for clade B HIV. The trial, designated HVTN 114, is being conducted by the HVTN and fund...

Maricann Group Inc. Announces Incident at Langton Facility

TORONTO, ONTARIO -- (Marketwired) -- 11/15/17 -- Maricann Group Inc. (CSE: MARI)(CSE: MARI.CN)(CNSX: MARI)(OTCQB: MRRCF)(FRANKFURT: 75M) ("Maricann" or the "Company") announced today that a small electrical fire occurred earlier today at its processing facility in Langton, Ontario. The fire was contained to a small area and the smoke was controlled to the immediate area of the fire. All employees...

Ceapro Reports 2017 Third Quarter Business Update and Financial Results

EDMONTON, ALBERTA -- (Marketwired) -- 11/15/17 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company") a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for the three-month and nine-month periods ended September 30, 2017 and provided an overview of recent o...


Quick Search
Advertisement
 

News Quicklinks